SCHEMBL3499430

SCHEMBL3499430

Cc1ccc(S(=O)(=O)N(C(N)=O)C2CCCCC2)cc1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 1/20 0.43
ALDH1A1 P00352 5/20 0.43
GAA P10253 1/20 0.43
THRB P10828 1/20 0.43
MAPK1 P28482 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
HTT P42858 2/20 0.41
TSHR P16473 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
KMT2A Q03164 3/20 0.40
NPSR1 Q6W5P4 2/20 0.40
MEN1 O00255 2/20 0.40
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.39
MAPT P10636 2/20 0.39
TP53 P04637 1/20 0.39
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
KDM4E B2RXH2 1/20 0.37
CNR2 P34972 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27768338 0.76 KMT2A (0.58) ALDH1A1GAAMAPK1SMN1; SMN2TSHR
SCHEMBL11874927 0.71 CA12 (0.44) ALDH1A1SMN1; SMN2HTTTSHRKMT2A
SCHEMBL6265475 0.69 ALDH1A1 (0.56) ALDH1A1GAATHRBSMN1; SMN2HTT
Metahexamide SCHEMBL30107709 0.68 ADORA3 (0.68) ALDH1A1GAATHRBSMN1; SMN2TSHR
Metahexamide SCHEMBL218071 0.68 ADORA3 (0.68) ALDH1A1GAATHRBSMN1; SMN2TSHR
Hydrochloric Acid SCHEMBL9796358 0.68 ALDH1A1 (0.71) ALDH1A1GAAMAPK1SMN1; SMN2HTT
SCHEMBL6954047 0.67 ALDH1A1 (0.54) ALDH1A1GAAMAPK1SMN1; SMN2HTT
SCHEMBL5474162 0.67 GAA (0.68) ALDH1A1GAAMAPK1SMN1; SMN2HTT
SCHEMBL21014310 0.67 ALDH1A1 (0.41) ALDH1A1GAATSHRTDP1KMT2A
SCHEMBL7997480 0.65 ALDH1A1 (0.46) ALDH1A1GAATSHRTDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100184033-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY Lineage Cell Therapeutics, Inc. 2010-07-22 US disclosed
US-20080226601-A1 Herpes Virus-Based Compositions and Methods of Use in the Prenatal and Perinatal Periods UNIVERSITY OF ROCHESTER (US) 2008-09-18 US disclosed
EP-1903873-A2 HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS THE UNIVERSITY OF ROCHESTER (US) 2008-04-02 EP disclosed
WO-2007062198-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY ADVANCED CELL TECHNOLOGY, INC. (US) 2007-05-31 WO disclosed
WO-2006135602-A2 HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS UNIVERSITY OF ROCHESTER (US) 2006-12-21 WO disclosed